Indication
Corneal Epithelial Degeneration
1 clinical trial
1 product
Product
TTHX1114Clinical trial
A Phase 1 Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of TTHX1114(NM141) Ophthalmic Solution In Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-04-12